Bulk Manufacturer of Controlled Substances Application: Noramco, 65608 [2022-23614]
Download as PDF
<![CDATA[
65608
Federal Register / Vol. 87, No. 209 / Monday, October 31, 2022 / Notices
minutes or the time taken to prepare
each response).
If additional information is required
contact: Robert Houser, Department
Clearance Officer, Policy and Planning
Staff, Office of the Chief Information
Officer, Justice Management Division,
United States Department of Justice,
Two Constitution Square, 145 N Street
NE, 3.E–206, Washington, DC 20530.
Dated: October 25, 2022.
Robert Houser,
Department Clearance Officer, Policy and
Planning Staff, Office of the Chief Information
Officer, U.S. Department of Justice.
[FR Doc. 2022–23591 Filed 10–28–22; 8:45 am]
BILLING CODE 4410–FY–P
DEPARTMENT OF JUSTICE
I
9652
9801
II
III
The company is a contract
manufacturer. At the request of the
company’s customers, it manufactures
derivatives of the above controlled
substances in bulk form. No other
activities for these drug codes are
authorized for this registration.
BILLING CODE 4410–09–P
Bulk Manufacturer of Controlled
Substances Application: Nanosyn Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Jkt 259001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1109]
Nanoysn Inc. has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before December 30, 2022. Such
persons may also file a written request
for a hearing on the application on or
before December 30, 2022.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Oxymorphone ...............
Fentanyl ........................
Schedule
[FR Doc. 2022–23609 Filed 10–28–22; 8:45 am]
[Docket No. DEA–1107]
17:15 Oct 28, 2022
Drug
code
Controlled substance
Kristi O’Malley,
Assistant Administrator.
Drug Enforcement Administration
VerDate Sep<11>2014
is notice that on September 2, 2022,
Nanosyn Inc., 3331 Industrial Drive,
Suite B, Santa Rosa, California 95403–
2062, applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
Bulk Manufacturer of Controlled
Substances Application: Noramco
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Noramco has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before December 30, 2022. Such
persons may also file a written request
for a hearing on the application on or
before December 30, 2022.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
SUMMARY:
PO 00000
Frm 00041
Fmt 4703
Sfmt 9990
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
In
accordance with 21 CFR 1301.33(a), this
is notice that on September 29, 2022,
Noramco, 500 Swedes Landing Road,
Wilmington, Delaware 19801–4417,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Gamma Hydroxybutyric
Acid.
Marihuana .....................
Tetrahydrocannabinols
Codeine-N-oxide ...........
Dihydromorphine ..........
Hydromorphinol ............
Morphine-N-oxide .........
Amphetamine ...............
Lisdexamfetamine ........
Methylphenidate ...........
Nabilone .......................
Phenylacetone ..............
Codeine ........................
Dihydrocodeine .............
Oxycodone ...................
Hydromorphone ............
Hydrocodone ................
Morphine .......................
Oripavine ......................
Thebaine .......................
Opium extracts .............
Opium fluid extract .......
Opium, tincture .............
Opium, powdered .........
Opium, granulated ........
Oxymorphone ...............
Noroxymorphone ..........
Tapentadol ....................
Drug
code
Schedule
2010
I
7360
7370
9053
9145
9301
9307
1100
1205
1724
7379
8501
9050
9120
9143
9150
9193
9300
9330
9333
9610
9620
9630
9639
9640
9652
9668
9780
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to bulk
manufacture the listed controlled
substances as an Active Pharmaceutical
Ingredient (API) for supply to its
customers. In reference to drug codes
7360 (Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
drug codes are authorized for this
registration.
Kristi O’Malley,
Assistant Administrator.
[FR Doc. 2022–23614 Filed 10–28–22; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\31OCN1.SGM
31OCN1
]]>Agencies
[Federal Register Volume 87, Number 209 (Monday, October 31, 2022)]
[Notices]
[Page 65608]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23614]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1109]
Bulk Manufacturer of Controlled Substances Application: Noramco
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Noramco has applied to be registered as a bulk manufacturer of
basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
December 30, 2022. Such persons may also file a written request for a
hearing on the application on or before December 30, 2022.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on September 29, 2022, Noramco, 500 Swedes Landing Road,
Wilmington, Delaware 19801-4417, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.............. 2010 I
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
Codeine-N-oxide........................ 9053 I
Dihydromorphine........................ 9145 I
Hydromorphinol......................... 9301 I
Morphine-N-oxide....................... 9307 I
Amphetamine............................ 1100 II
Lisdexamfetamine....................... 1205 II
Methylphenidate........................ 1724 II
Nabilone............................... 7379 II
Phenylacetone.......................... 8501 II
Codeine................................ 9050 II
Dihydrocodeine......................... 9120 II
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Hydrocodone............................ 9193 II
Morphine............................... 9300 II
Oripavine.............................. 9330 II
Thebaine............................... 9333 II
Opium extracts......................... 9610 II
Opium fluid extract.................... 9620 II
Opium, tincture........................ 9630 II
Opium, powdered........................ 9639 II
Opium, granulated...................... 9640 II
Oxymorphone............................ 9652 II
Noroxymorphone......................... 9668 II
Tapentadol............................. 9780 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances as an Active Pharmaceutical Ingredient (API) for supply to
its customers. In reference to drug codes 7360 (Marihuana), and 7370
(Tetrahydrocannabinols), the company plans to bulk manufacture these
drugs as synthetic. No other activities for these drug codes are
authorized for this registration.
Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-23614 Filed 10-28-22; 8:45 am]
BILLING CODE 4410-09-P
